Magnesium sulfate and intraocular pressure

Intraocular pressure changes following administration of suxamethonium and endotracheal intubation: Influence of two different doses of magnesium sulfate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201510001277321

Enrollment

136

Registered

2015-09-26

Start date

2015-01-26

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Group C

Group M1

Group M2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 120 patients, their ages ranged between 18 and 60 years, ASA physical status class I and II underwent elective cataract surgery.

Exclusion criteria

Exclusion criteria: known hypersensitivity to magnesium sulphate or succinylcholine hypocalcaemia any degree of heart block hypertensive obese (BMI >30) any cardiovascular, renal, hepatic or muscular disease patients with raised IOP previous eye surgery patients receiving any drug known to alter IOP

Design outcomes

Primary

Measure	Time frame
Intraocular pressure (IOP)	—

Secondary

Measure	Time frame
- Hemodynamic parameters: heart rate (HR) and mean arterial blood pressure (MAP).	—

Countries

Egypt

Contacts

Public ContactAhmed Tohamy

Lecturer

atohamy80@gmail.com00201008700759

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026